Autoimmune thyroid diseases as a cost of physiological autoimmune surveillance.

Graves' disease Hashimoto's thyroiditis autoimmune etiology physiological autoimmunity systems immunology thyroid autoimmune diseases

Journal

Trends in immunology
ISSN: 1471-4981
Titre abrégé: Trends Immunol
Pays: England
ID NLM: 100966032

Informations de publication

Date de publication:
05 2023
Historique:
received: 16 02 2023
revised: 09 03 2023
accepted: 09 03 2023
medline: 1 5 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

Graves' disease (GD) and Hashimoto's thyroiditis (HT) are common autoimmune diseases of the thyroid gland, causing hyperthyroidism and hypothyroidism, respectively. Despite their opposing clinical manifestation, they have several enigmatic links. Here, we propose that GD and HT have the same fundamental origin: both diseases are the cost of a beneficial physiological process called autoimmune surveillance of hypersecreting mutants. Autoreactive T cells selectively eliminate mutant cells that hypersecrete the hormones and threaten to become toxic nodules. These T cells can trigger a humoral response in susceptible individuals, leading to the production of antibodies against thyroid antigens. This shared origin can explain similarities in incidence and risk factors between HT and GD, despite their opposite clinical phenotypes.

Identifiants

pubmed: 37061365
pii: S1471-4906(23)00051-0
doi: 10.1016/j.it.2023.03.007
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

365-371

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests None declared by authors.

Auteurs

Tomer Milo (T)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.

Yael Korem Kohanim (Y)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Yoel Toledano (Y)

Division of Maternal Fetal Medicine, Helen Schneider Women's Hospital, Rabin Medical Center, Petah Tikva, 4941492 Israel.

Uri Alon (U)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel. Electronic address: uri.alon@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH